Navigation Links
ShangPharma to Attend Two Upcoming Investor Conferences
Date:11/28/2011

SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it is scheduled to present at the following investor conferences in December 2011:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will present at the following conferences:

  • Deutsche Bank 5th Annual MedTools Investor Summit, December 5-6, 2011, Boston
  • Oppenheimer 22nd Annual Healthcare Conference, December 13-14, 2011, New York City

  • Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at http://ir.shangpharma.com.

    ABOUT SHANGPHARMA CORPORATIONShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.For further information, please contact:  ShangPharma Ms. Lan XieVP of Finance and Investor RelationsEmail: ir@shangpharma.comBrunswick GroupLilian WongEmail: shangpharma@brunswickgroup.com Phone: 86-10-5960-8600
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ShangPharma Announces Third Quarter 2011 Results
    2. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
    3. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
    4. ShangPharma Corporation Announces Resignation of a Director
    5. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
    6. ShangPharma Announces Up to $10 Million Share Repurchase Program
    7. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
    8. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
    9. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
    10. ShangPharma Announces Fourth Quarter and Fiscal Year 2010 Results
    11. ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
    (Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
    (Date:7/6/2017)... ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is celebrating a ... To celebrate its anniversary, ThriveRx recently launched a redesigned website ... with improved organization to create the best user experience for consumers and ... ... "We,ve made several great strides throughout the ...
    Breaking Medicine Technology:
    (Date:7/24/2017)... ... 24, 2017 , ... BayMark Health Services has been awarded ... (SAMHSA) State Targeted Response to the Opioid Crisis program. The funding, awarded ... development of a hub and spoke model for opioid treatment in California. The ...
    (Date:7/24/2017)... ... July 24, 2017 , ... Every year, thousands of dedicated Higher Education and ... annual event is coupled with a dynamic theme like Camp Canvas; this year, they’ve ... InstructureCon 0017. , To extend their partnership with Canvas beyond the LMS integration, ...
    (Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global leader in ... of United States Patent Number 9,695,398 (the '398 patent) and South Korean Patent ... and '324 patents cover methods and systems for optimizing fat grafts for current ...
    (Date:7/24/2017)... ... 2017 , ... Paul Vitenas, MD, FACS is excited to report that he ... attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the top ... bringing a newly defined structure to the aesthetics market. Dr. Vitenas , along ...
    (Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – Arlington, VA, ... Friday, July 28. , Increased FDA scrutiny and growing demands to track and ...
    Breaking Medicine News(10 mins):